SCHEMBL7407182

SCHEMBL7407182

CCCCOC(=O)Nc1ccc(Br)cc1F

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.53
NPC1 O15118 5/20 0.53
RAB9A P51151 5/20 0.53
ALDH1A1 P00352 6/20 0.50
L3MBTL1 Q9Y468 4/20 0.50
HPGD P15428 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2C19 P33261 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MAPT P10636 3/20 0.49
POLB P06746 1/20 0.49
GAA P10253 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
LMNA P02545 3/20 0.48
TSHR P16473 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
FPR2 P25090 1/20 0.47
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29348997 0.86 NPC1 (0.47) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL3279766 0.86 CYP1A2 (0.58) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL16696397 0.85 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL31078996 0.85 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL30729910 0.85 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL16696407 0.82 RAB9A (0.47) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL12502270 0.82 HPGD (0.48) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL12502268 0.82 HPGD (0.48) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL10415979 0.80 SMN1; SMN2 (0.66) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1
SCHEMBL16654381 0.80 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9AALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015066413-A1 OXAZOLIDINONE HYDROXAMIC ACID COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS NOVARTIS AG (CH) 2015-05-07 WO disclosed
EP-0946508-A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-10-06 EP disclosed
WO-1998028269-A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed